  The optimization of the 4-methoxy-6-azaindole series of HIV-1 attachment inhibitors ( AIs) that originated with 1 to deliver temsavir ( 3 , BMS-626529) is described. The most beneficial increases in potency and pharmacokinetic ( PK) properties were attained by incorporating N-linked , sp